{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:12:32Z","timestamp":1793686352867,"version":"4.5.1"},"reference-count":54,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2024,4,12]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Cardiovascular comorbidities are common in patients with autoimmune diseases. This study investigates the extent of subclinical atherosclerosis in patients with primary Sj\u00f6gren\u2019s syndrome (pSS). Correlations with clinical factors such as organ involvement (OI) or disease activity were analysed and oxLDL antibodies (oxLDL ab) were measured as potential biomarkers of vascular damage.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with pSS were consecutively included from the rheumatology outpatient clinic. Age- and sex-matched controls were recruited (2:1 ratio). Data collection was performed by a standardised questionnaire and Doppler ultrasound to evaluate the plaque extent and carotid intima-media thickness (cIMT). Propensity score matching included all cardiovascular risk (CVR) factors and corresponding laboratory markers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Data were available for 299 participants (199 pSS\/100 controls), aged 59.4 years (50.6\u201365.0), 19.1% male. After matching, the pSS cohort had greater cIMT (p&lt;0.001) and plaque extent (OR=1.82; 95% CI 1.14 to 2.95). Subgroup analyses of patients with pSS revealed that OI was associated with increased cIMT (p=0.025) and increased plaque occurrence compared with patients without OI (OR=1.74; 95% CI 1.02 to 3.01). OxLDL ab tended to be lower in patients with plaque (p=0.052). Correlations of higher Oxidized Low Density Lipoprotein (oxLDL) ab with EULAR Sj\u00f6gren\u2019s Syndrome Disease Activity Index (p&lt;0.001) and anti\u2013Sj\u00f6gren's-syndrome-related antigen A autoantibodies (SSA\/Ro antibodies) (p=0.026) were observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Subclinical atherosclerosis occurs earlier and more severely in patients with pSS. The difference in cIMT between pSS and controls seems mainly driven by patients with OI, suggesting that this subgroup is particularly at risk. OxLDL ab might protect against atherosclerotic progression in patients with pSS. CVR stratification and preventive medications such as Hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors should be discussed and further longitudinal studies are needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003559","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T02:40:49Z","timestamp":1714012849000},"page":"e003559","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Primary Sj\u00f6gren\u2019s syndrome independently promotes premature subclinical atherosclerosis"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1556-790X","authenticated-orcid":false,"given":"Nadine","family":"Zehrfeld","sequence":"first","affiliation":[{"name":"Rheumatology & Immunology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Abelmann","sequence":"additional","affiliation":[{"name":"Cardiology & Angiology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Benz","sequence":"additional","affiliation":[{"name":"Faculty of Social Sciences, University of Mannheim, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Luisa","family":"Zippel","sequence":"additional","affiliation":[{"name":"Rheumatology & Immunology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Beider","sequence":"additional","affiliation":[{"name":"Rheumatology & Immunology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelie","family":"Kramer","sequence":"additional","affiliation":[{"name":"Rheumatology & Immunology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6018-6826","authenticated-orcid":false,"given":"Tabea","family":"Seeliger","sequence":"additional","affiliation":[{"name":"Neurology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Sogkas","sequence":"additional","affiliation":[{"name":"Rheumatology & Immunology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vega","family":"G\u00f6decke","sequence":"additional","affiliation":[{"name":"Rheumatology & Immunology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Ahrenstorf","sequence":"additional","affiliation":[{"name":"Rheumatology & Immunology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz Paul","family":"Armbruster","sequence":"additional","affiliation":[{"name":"Immundiagnostik AG, Bensheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skripuletz","sequence":"additional","affiliation":[{"name":"Neurology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[{"name":"Rheumatology & Immunology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm Arthur","family":"Derda","sequence":"additional","affiliation":[{"name":"Cardiology & Angiology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sonnenschein","sequence":"additional","affiliation":[{"name":"Cardiology & Angiology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ernst","sequence":"additional","affiliation":[{"name":"Rheumatology & Immunology, Hannover Medical School, Hannover, Lower Saxony, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"2025090313082748000_10.2.e003559.1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5152\/eurjrheum.2021.20093","article-title":"Primary Sj\u00f6gren\u2019s syndrome as independent risk factor for Subclinical Atherosclerosis","volume":"9","author":"Novella-Navarro","year":"2022","journal-title":"Eur J Rheumatol"},{"key":"2025090313082748000_10.2.e003559.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205375"},{"key":"2025090313082748000_10.2.e003559.3","first-page":"460","article-title":"Rheumatoid arthritis and Atherosclerosis","volume":"21","author":"Adawi","year":"2019","journal-title":"Isr Med Assoc J"},{"key":"2025090313082748000_10.2.e003559.4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.17219\/acem\/29847","article-title":"Disease activity, Oxidized-LDL fraction and anti-Oxidized LDL antibodies influence cardiovascular risk in rheumatoid arthritis","volume":"25","author":"Nowak","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"2025090313082748000_10.2.e003559.5","first-page":"190","article-title":"Association between primary Sj\u00f6gren\u2019s syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis","volume":"36 Suppl 112","author":"Yong","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313082748000_10.2.e003559.6","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000092891.55157.A7"},{"key":"2025090313082748000_10.2.e003559.7","first-page":"133","article-title":"Atherosclerosis in Sj\u00f6gren\u2019s syndrome: evidence, possible mechanisms and knowledge gaps","volume":"34","author":"Valim","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313082748000_10.2.e003559.8","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000864","article-title":"Generic and disease-adapted cardiovascular risk scores as predictors of Atherosclerosis progression in SLE","volume":"10","author":"Panopoulos","year":"2023","journal-title":"Lupus Sci Med"},{"key":"2025090313082748000_10.2.e003559.9","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0613-6","article-title":"Subclinical Atherosclerosis and impaired bone health in patients with primary Sjogren\u2019s syndrome: prevalence, clinical and laboratory associations","volume":"17","author":"Gravani","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2025090313082748000_10.2.e003559.10","first-page":"113","article-title":"The prevalence and relevance of traditional cardiovascular risk factors in primary Sj\u00f6gren\u2019s syndrome","volume":"36 Suppl 112","author":"Bartoloni","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313082748000_10.2.e003559.11","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1246818","article-title":"Current and emerging evidence for toll-like receptor activation in Sj\u00f6gren\u2019s syndrome","volume":"2018","author":"Kiripolsky","year":"2018","journal-title":"J Immunol Res"},{"key":"2025090313082748000_10.2.e003559.12","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1007\/s00415-023-11613-5","article-title":"Sj\u00f6gren\u2019s syndrome with and without neurological involvement","volume":"270","author":"Seeliger","year":"2023","journal-title":"J Neurol"},{"key":"2025090313082748000_10.2.e003559.13","doi-asserted-by":"crossref","unstructured":"Peng Y , Wu X , Zhang S , et al . The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (nets) in the pathogenesis of primary Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther 2022;24. doi:10.1186\/s13075-022-02860-4","DOI":"10.1186\/s13075-022-02860-4"},{"key":"2025090313082748000_10.2.e003559.14","article-title":"Rate, risk factors and causes of mortality in patients with Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Singh","year":"2016","journal-title":"Rheumatology"},{"key":"2025090313082748000_10.2.e003559.15","doi-asserted-by":"crossref","first-page":"697157","DOI":"10.3389\/fimmu.2021.697157","article-title":"Integrated Bioinformatics and validation reveal potential biomarkers associated with progression of primary Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"2025090313082748000_10.2.e003559.16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4533"},{"key":"2025090313082748000_10.2.e003559.17","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2011-130214"},{"key":"2025090313082748000_10.2.e003559.18","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1048684","article-title":"Premature stroke and cardiovascular risk in primary Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Zippel","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025090313082748000_10.2.e003559.19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/RHU.0000000000000413","article-title":"Asymptomatic Atherosclerosis in primary Sj\u00f6gren syndrome: correlation between low ankle brachial index and Autoantibodies positivity","volume":"22","author":"Garcia","year":"2016","journal-title":"J Clin Rheumatol"},{"key":"2025090313082748000_10.2.e003559.20","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/463620","article-title":"Cardiac manifestations of Rheumatological conditions: a narrative review","volume":"2012","author":"Owlia","year":"2012","journal-title":"ISRN Rheumatol"},{"key":"2025090313082748000_10.2.e003559.21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.ATV.20.3.703","article-title":"Antibodies against Oxidized LDL and carotid artery intima-media thickness in a healthy population","volume":"20","author":"Fukumoto","year":"2000","journal-title":"ATVB"},{"key":"2025090313082748000_10.2.e003559.22","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1398.036"},{"key":"2025090313082748000_10.2.e003559.23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00393-005-0733-5","article-title":"Accelerated Atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?","volume":"64","author":"Fischer-Betz","year":"2005","journal-title":"Z Rheumatol"},{"key":"2025090313082748000_10.2.e003559.24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10067-018-4265-1","article-title":"Association between primary Sjogren\u2019s syndrome, arterial stiffness, and Subclinical Atherosclerosis: a systematic review and meta-analysis","volume":"38","author":"Yong","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2025090313082748000_10.2.e003559.25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/joim.12346","article-title":"Cardiovascular disease risk burden in primary Sj\u00f6gren\u2019s syndrome: results of a population-based Multicentre cohort study","volume":"278","author":"Bartoloni","year":"2015","journal-title":"J Intern Med"},{"key":"2025090313082748000_10.2.e003559.26","unstructured":"Chiang C-H , Liu C-J , Chen P-J , et al . Primary Sj\u00f6gren\u2019s syndrome and the risk of acute myocardial infarction: a nationwide study. 2013;29:124\u201331."},{"key":"2025090313082748000_10.2.e003559.27","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-1961-4","article-title":"Proteomic and histopathological Characterisation of sicca subjects and primary Sj\u00f6gren\u2019s syndrome patients reveals promising tear, saliva and extracellular Vesicle disease biomarkers","volume":"21","author":"Aqrawi","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025090313082748000_10.2.e003559.28","doi-asserted-by":"publisher","DOI":"10.1080\/10446670410001722186"},{"key":"2025090313082748000_10.2.e003559.29","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.21.5.656"},{"key":"2025090313082748000_10.2.e003559.30","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22934"},{"key":"2025090313082748000_10.2.e003559.31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.17219\/acem\/61434","article-title":"Serum ICAM-1, VCAM-1 and E-Selectin levels in patients with primary and secondary Sj\u00f6gren\u2019s syndrome","volume":"26","author":"B\u0142ochowiak","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"2025090313082748000_10.2.e003559.32","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#"},{"key":"2025090313082748000_10.2.e003559.33","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/234316","article-title":"Proatherogenic Oxidized low-density lipoprotein\/\u03922-glycoprotein I complexes in arterial and venous disease","volume":"2014","author":"Berger","year":"2014","journal-title":"J Immunol Res"},{"key":"2025090313082748000_10.2.e003559.34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40119-022-00261-x","article-title":"Evaluation of intima-media thickness and arterial stiffness as early ultrasound biomarkers of carotid artery Atherosclerosis","volume":"11","author":"Fern\u00e1ndez-Alvarez","year":"2022","journal-title":"Cardiol Ther"},{"key":"2025090313082748000_10.2.e003559.35","doi-asserted-by":"publisher","DOI":"10.3109\/10715762.2011.645206"},{"key":"2025090313082748000_10.2.e003559.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2018.05.010"},{"key":"2025090313082748000_10.2.e003559.37","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev200"},{"key":"2025090313082748000_10.2.e003559.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.coms.2013.09.008"},{"key":"2025090313082748000_10.2.e003559.39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"American college of rheumatology\/European League against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: A consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090313082748000_10.2.e003559.40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0025-7753(02)73351-4","article-title":"Atherosclerosis and anti-Oxidized low density lipoprotein antibodies in an elderly population","volume":"119","author":"Balada","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"2025090313082748000_10.2.e003559.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(02)00100-3"},{"key":"2025090313082748000_10.2.e003559.42","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/nu13062072","article-title":"Cardiovascular risk and endothelial dysfunction in primary Sjogren syndrome is related to the disease activity","volume":"13","author":"\u0141uczak","year":"2021","journal-title":"Nutrients"},{"key":"2025090313082748000_10.2.e003559.43","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.155"},{"key":"2025090313082748000_10.2.e003559.44","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.tripleo.2008.09.015","article-title":"Association between IFN-alpha and primary Sjogren\u2019s syndrome","volume":"107","author":"Zheng","year":"2009","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"},{"key":"2025090313082748000_10.2.e003559.45","doi-asserted-by":"publisher","DOI":"10.1191\/0961203306lu2267oa"},{"key":"2025090313082748000_10.2.e003559.46","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009302"},{"key":"2025090313082748000_10.2.e003559.47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00817","article-title":"Subclinical Atherosclerosis in primary Sj\u00f6gren\u2019s syndrome does inflammation matter?","volume":"10","author":"Bartoloni","year":"2019","journal-title":"Front Immunol"},{"key":"2025090313082748000_10.2.e003559.48","doi-asserted-by":"publisher","DOI":"10.1177\/039463201402700422"},{"key":"2025090313082748000_10.2.e003559.49","first-page":"11922","article-title":"Roles of antibody against Oxygenized low density lipoprotein in Atherosclerosis: recent advances","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin"},{"key":"2025090313082748000_10.2.e003559.50","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204615"},{"key":"2025090313082748000_10.2.e003559.51","first-page":"331","article-title":"Anti-ox-LDL antibodies and anti-ox-LDL-B2Gpi antibodies in patients with systemic lupus erythematosus","volume":"21","author":"Nowak","year":"2012","journal-title":"Adv Clin Exp Med"},{"key":"2025090313082748000_10.2.e003559.52","unstructured":"Cinoku I , Mavragani CP , Costantinos CT , et al . Autoantibodies to ox-LDL in Sj\u00f6gren\u2019s syndrome: are they Atheroprotective? Clin Exp Rheumatol 2018;61\u20137."},{"key":"2025090313082748000_10.2.e003559.53","doi-asserted-by":"publisher","DOI":"10.1159\/000098211"},{"key":"2025090313082748000_10.2.e003559.54","doi-asserted-by":"publisher","DOI":"10.1159\/000343145"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:08:36Z","timestamp":1756930116000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,24]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/rmdopen-2023-003559"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003559","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}